BETTINA SMITH: Open Payments
NPI 1245980655 · BROOKSVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,327 in 118 payments from 14 companies in 2025. Trend: 2023 $201 · 2024 $1,261 · 2025 $3,327
Food & beverage: $3,220Education: $107
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $405 |
| Otsuka America Pharmaceutical, Inc. | 14 | $372 |
| Alkermes, Inc. | 12 | $365 |
| E.R. Squibb & Sons, L.L.C. | 10 | $363 |
| Teva Pharmaceuticals USA, Inc. | 18 | $360 |
| Axsome Therapeutics, Inc. | 12 | $296 |
| Indivior Inc. | 7 | $238 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $196 |
| Janssen Pharmaceuticals, Inc | 7 | $190 |
| Vanda Pharmaceuticals Inc. | 9 | $187 |
Products named: INGREZZA, COBENFY, Auvelity, SUBLOCADE, CAPLYTA, ARISTADA, VRAYLAR, FANAPT.
Industry payments across FL — which companies pay providers there.
